The trend: Pharma companies are increasing their advertising presence on linear TV, according to a recent report from iSpot.tv. The report analyzed pharma ads on linear TV from January through August of this year.
The topline findings on pharma’s traditional TV ad spending:
Top TV programs for Rx ads: Nearly half (48%) of household TV ad impressions for prescription drug brands were split between ABC, CBS, CNN, Fox News, ION, MSNBC, and NBC.
Drug ads were most prevalent on cable news, re-runs of popular dramas and game shows, and special event programming.
TV is important for targeting older consumers: US adults are spending less time with linear TV each year, per our estimates. However, older patients are pharma’s top priority—and they’re the folks most likely to consume traditional media.
We forecast that US consumers ages 65+ spend on average over 5 hours per day with linear TV, while those in the 55 to 64 age group watch about 4 hours a day. Comparatively, consumers under 44 years old watch less than 2 hours of TV per day, with most Gen Zers not even reaching the 1-hour mark.
The 65+ demographic is extremely lucrative to pharma brands.
Key stat: Healthcare and pharma marketers lean heavier on traditional media than any other singular sector EMARKETER measured in our recent ad spending benchmarks per industry.
The final word: Linear TV isn’t the only television format top-of-mind for pharma advertisers.
Pharma brands are also devoting resources to connected TV (CTV), which lets marketers integrate longer-form video content into platforms where consumers are increasingly spending more time. CTV/streaming was ranked as the No. 2 most important consumer trend that healthcare and pharma marketers are monitoring in H2 2024, per a recent Mediaocean report. It ranked only behind genAI.
Go deeper with our US Healthcare and Pharma Ad Spending 2024 report.
This article is part of EMARKETER’s client-only subscription Briefings—daily newsletters authored by industry analysts who are experts in marketing, advertising, media, and tech trends. To help you finish 2024 strong, and start 2025 off on the right foot, articles like this one—delivering the latest news and insights—are completely free through January 31, 2025. If you want to learn how to get insights like these delivered to your inbox every day, and get access to our data-driven forecasts, reports, and industry benchmarks, schedule a demo with our sales team.